Develops pharmaceutical products for the treatment of cancer and pain
Company profile
Ticker
IMNPQ
Exchange
Website
CEO
Gary Rabin
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
EPICEPT CORP
SEC CIK
Corporate docs
IRS number
521841431
IMNPQ stock data
Latest filings (excl ownership)
REVOKED
Registration or securities revoked
18 Aug 22
8-K
Completion of Acquisition or Disposition of Assets
13 Apr 21
8-K
Departure of Directors or Certain Officers
12 Apr 21
8-K
Bankruptcy or Receivership
8 Mar 19
8-K
Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
14 Feb 19
424B4
Prospectus supplement with pricing info
7 Feb 19
S-1/A
IPO registration (amended)
17 Jan 19
25-NSE
Exchange delisting
8 Jan 19
S-1/A
IPO registration (amended)
19 Dec 18
8-K
Amendments to Articles of Incorporation or Bylaws
19 Dec 18
Latest ownership filings
4
Anthony S. Fiorino
4 Feb 20
SC 13G
Immune Pharmaceuticals Inc
12 Aug 19
3
John P Clark
20 Nov 18
4
Anthony S. Fiorino
23 May 18
4
Anthony S. Fiorino
18 May 18
SC 13G/A
Immune Pharmaceuticals Inc
14 Feb 18
3
Anthony S. Fiorino
18 Sep 17
4
Anthony S. Fiorino
18 Sep 17
4
Elliot M Maza
20 Jul 17
SC 13G
Immune Pharmaceuticals Inc
28 Jun 17
Institutional ownership, Q3 2019
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|